XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 24.85

-7.7%

Feb 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (4822)	11/21/1997 4:19:00 PM
From: Arthur Radley	Read Replies (2) of 17367

Off Topic: I had the opportunity to visit with the science director for ARNX this morning. He was very positive about the pipe line of drugs that they have in various trial stages. They expect to file a NDA for NYOTRAN in the near future.They also expect to file for drug approval for one of their compounds in Spain in the very near future. They also have a drug(Atragen) that they expect to file for NDA. This particular drug will probably compete with LGND for the Kaposi's sarcoma market. Have you ever looked at ARNX and do you have an opinion?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next